Websites, Message Boards, Lists, Discussion Groups,
Zines & Newsletters
|
|
|
|
Publications Office Based Opioid Treatment Federal Code U.S. Federal Code. Confidentiality of Alcohol and Drug Abuse Patient Records. U.S. Federal Code. Medical Privacy HIPPA, National Standards to Protect the Privacy of Personal Health Information. Public Law 106-310, 106th Congress Sec. 3502. Controlled Substances Act, October 17, 2000. Physician Waiver to Prescribe, Dispense Schedule III-V Narcotic Drugs in the…
Best Practices: Treatment of Opiate Dependence Conference Update Physician Training for Use of Buprenorphine The conference planning committee working with the Center for Substance Abuse Treatment and the American Academy of Addictions Psychiatry will be offering the following 8-hour physician workshop during the Best Practices: Treatment of Opiate Dependence Conference, scheduled for March…
Changes in Methadone Treatment Practices: Results From a National Panel Study, 1988-2000 by Thomas D’Aunno, PhD; Harold A. Pollack, PhD Journal of the American Medical Association Vol. 288, No. 7 August 21, 2002 Context Results from several studies conducted in the early 1990s showed that the majority of US methadone maintenance programs did not use…
Policy Statement Number 6 August 1995 NAMA is well aware of the importance Methadone Anonymous has had on patients across the United States. Organizing a 12 step group is hard work and the commitment of Methadone Anonymous to the recovery of methadone patients is apparent. Methadone Anonymous contends with the same discrimination and stigma that…
How much do you really know about methadone? Take NAMA’s Methadone Awareness Test and find out! Most Frequently Asked Question: Is methadone maintenance “trading one addiction for another” Answer Pregnant women should withdraw or at least lower their dose of methadone so that the baby is not born dependent. True or false? Answer Methadone…
NAMA wishes to thank the National Institute on Drug Abuse (NIDA) and the Center for Substance Abuse Treatment (CSAT) for their Support of Certified Methadone Advocate Training at the 2003 AATOD Conference in Washington DC. NAMA wishes to offer special thanks to Mallinckrodt and American Association for the Treatment of Opioid Dependence (AATOD).